» Articles » PMID: 31478096

Expression and Localization of the Small Proteoglycans Decorin and Biglycan in Articular Cartilage of Kashin-Beck Disease and Rats Induced by T-2 Toxin and Selenium Deficiency

Overview
Journal Glycoconj J
Publisher Springer
Date 2019 Sep 4
PMID 31478096
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Kashin-Beck disease (KBD) is an endemic degenerative osteoarthropathy of uncertain etiology. Our study sought to identify a correlation between small proteoglycans decorin and biglycan expression and Kashin-Beck Disease. Immunohistochemistry was used to assess the decorin and biglycan levels in cartilage specimens from both child KBD patients, and rats fed with T-2 toxin under a selenium-deficient condition. Real-time PCR and Western blot were used to assess mRNA and protein levels of decorin and biglycan in rat cartilages, as well as in C28/I2 chondrocytes stimulated by T-2 toxin and selenium in vitro. The result showed that decorin was reduced in all zones of KBD articular cartilage, while the expression of biglycan was prominently increased in KBD cartilage samples. Increased expression of biglycan and reduced expression of decorin were observed at mRNA and protein levels in the cartilage of rats fed with T-2 toxin and selenium- deficiency plus T-2 toxin diet, when compared with the normal diet group. Moreover, In vitro stimulation of C28/I2 cells with T-2 toxin resulted in an upregulation of biglycan and downregulation of decorin, T-2 toxin induction of biglycan and decorin levels were partly rescued by selenium supplement. This study highlights the focal nature of the degenerative changes that occur in KBD cartilage and may suggest that the altered expression pattern of decorin and biglycan have an important role in the onset and pathogenesis of KBD.

Citing Articles

Differential expression of cyclins CCNB1 and CCNG1 is involved in the chondrocyte damage of kashin-beck disease.

Setiwalidi K, Fu J, Hei H, Nuer S, Zhang F, Chen S Front Genet. 2023; 13:1053685.

PMID: 36588792 PMC: 9794764. DOI: 10.3389/fgene.2022.1053685.


Proteoglycans in Toll-like receptor responses and innate immunity.

Garantziotis S, Savani R Am J Physiol Cell Physiol. 2022; 323(1):C202-C214.

PMID: 35675639 PMC: 9273283. DOI: 10.1152/ajpcell.00088.2022.


Biglycan: an emerging small leucine-rich proteoglycan (SLRP) marker and its clinicopathological significance.

Appunni S, Rubens M, Ramamoorthy V, Anand V, Khandelwal M, Sharma A Mol Cell Biochem. 2021; 476(11):3935-3950.

PMID: 34181183 DOI: 10.1007/s11010-021-04216-z.


Aggrecan, the Primary Weight-Bearing Cartilage Proteoglycan, Has Context-Dependent, Cell-Directive Properties in Embryonic Development and Neurogenesis: Aggrecan Glycan Side Chain Modifications Convey Interactive Biodiversity.

Hayes A, Melrose J Biomolecules. 2020; 10(9).

PMID: 32867198 PMC: 7564073. DOI: 10.3390/biom10091244.


From Translation to Protein Degradation as Mechanisms for Regulating Biological Functions: A Review on the SLRP Family in Skeletal Tissues.

Zappia J, Joiret M, Sanchez C, Lambert C, Geris L, Muller M Biomolecules. 2020; 10(1).

PMID: 31947880 PMC: 7023458. DOI: 10.3390/biom10010080.

References
1.
Merline R, Schaefer R, Schaefer L . The matricellular functions of small leucine-rich proteoglycans (SLRPs). J Cell Commun Signal. 2009; 3(3-4):323-35. PMC: 2778586. DOI: 10.1007/s12079-009-0066-2. View

2.
Sztrolovics R, White R, Poole A, Mort J, Roughley P . Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism. Biochem J. 1999; 339 ( Pt 3):571-7. PMC: 1220192. View

3.
Stander M, Naumann U, Wick W, Weller M . Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res. 1999; 296(2):221-7. DOI: 10.1007/s004410051283. View

4.
Tian L, Wang W, Hou W, Tian J, Zhong N, Sun J . Autoimmune and inflammatory responses in Kashin-Beck disease compared with rheumatoid arthritis and osteoarthritis. Hum Immunol. 2011; 72(10):812-6. DOI: 10.1016/j.humimm.2011.05.021. View

5.
Beavan L, Schonherr E, Snigula F, Leroy J, Kresse H . Deficient expression of decorin in infantile progeroid patients. J Biol Chem. 1993; 268(13):9856-62. View